This week in gene and cell therapy - 20 April 2018

Gene and cell therapy headlines 16 - 20 April

Novartis acquires AveXis, including the AVXS-101 treatment for SMA

Pfizer and Allogene to collaborate on developing donor-derived CAR T-cell therapies

Orchard Therapeutics acquires GSK rare disease gene therapy portfolio

Pfizer launching phase 1b trial of gene therapy for Duchenne muscular dystrophy

Personalised cancer vaccine directs T-cell response to ovarian cancer

Goldman Sachs report highlights need for gene therapy pricing strategy

Clinical trial shows gene therapy for beta-thalassemia is safe and effective

Trial of CRISPR to treat beta-thalassemia to start in Europe

GE launching prefabricated manufacturing units for producing virus-based gene and cell therapies